ReviewMolecular cancer2026
The multifaceted functions of selective autophagy in cancer: molecular basis, consequences, and clinical prospects.
Review in Molecular cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selective autophagy is a critical cellular process in eukaryotic cells, characterized by the targeted degradation of specific organelles and proteins. This intricate mechanism plays a vital role in maintaining cellular homeostasis and has significant implications in the pathogenesis and progression of various diseases, notably cancer. Recent studies have highlighted the dual role of selective autophagy in cancer, acting both as a suppressor in the early stages and potentially facilitating progression in later stages. The complexity of selective autophagy, particularly in the context of oncogenesis, presents unique challenges. This review focuses on the molecular mechanisms underlying selective autophagy, its impact on cancer development and progression, and the challenges in leveraging this process for therapeutic interventions. We discuss the interplay between autophagy and cancer, examining how alterations in autophagic pathways contribute to tumorigenesis and the resistance of cancer cells to therapy. Additionally, we explore the potential of targeting selective autophagy pathways as a novel approach in cancer treatment, considering the challenges and prospects of such strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.